Journal Article (Erratum/Correction) DKFZ-2026-01737

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
BioMed Central [Erscheinungsort nicht ermittelbar]

Clinical epigenetics 18(1), 136 () [10.1186/s13148-026-02203-z]
 GO

Abstract: In article [1], The corresponding author inadvertently omitted the declaration of the Competing Interest in the original submission. This has now been corrected, and the statement has been added as indicated below.The new Competing interest:“Stefan Wiemann is an Associate Editor of Clinical Epigenetics. To ensure an independent and unbiased review process, Stefan Wiemann had no involvement in the peer review, editorial assessment, or decision-making for this manuscript. The remaining authors declare no competing interests.”The original article has been corrected.

Classification:

Note: #EA:B050#LA:B050#

Contributing Institute(s):
  1. Molekulare Genomanalyse (B050)
  2. Zelluläre Tools (W111)
  3. Epigenomik (B370)
  4. Metabolismus und Microenvironment (A410)
  5. Lehrveranstaltungen (W071)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2026
Database coverage:
Medline ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-07-13, last modified 2026-07-15


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)